In the present study, comparative efficacy of ceftriaxone sulbactam and ceftriaxone tazobactam combinations against Bacillus subtilis (MTCC NO. – 736), Pseudomonas aeruginosa (MTCC NO. – 1688), Escherichia coli (MTCC NO. – 739) and Klebsiella pneumoniae ( MTCC NO. – 109) was observed. Antibiotic Susceptibility Test (AST) and Minimum Inhibitory Concentration (MIC) of ceftriaxone, sulbactam, tazobactam, ceftriaxone sulbactam combination and ceftriaxone tazobactam combination were analyzed. The percentage effectiveness of ceftriaxone sulbactam and ceftriaxone tazobactam varied for each bacterial species. The difference of effectiveness between the two antibiotics ranged between 0.48 % to 20.65 %. The maximum difference in effectiveness was noticed against E. coli (20.65%) and the least was observed against P. aeruginosa (0.48%). The MIC value for ceftriaxone sulbactam combination was found to be less as compared to ceftriaxone, sulbactam, tazobactam and ceftriaxone tazobactam combination. In conclusion, the AST and MIC revealed that ceftriaxone sulbactam combination was more effective and can be an excellent therapeutic alternative of ceftriaxone tazobactam and ceftriaxone alone.
Minimum Inhibitory Concentration (MIC), Antibiotic Susceptibility Test (AST), Ceftriaxone, Sulbactam , Tazobactam
© The Author(s) 2009. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.